Datacubed Health combines academic theory with ground-breaking technology.
Our company includes senior scholars with experience in hundreds of clinical research trials as well as veteran industry executives and leading engineers. The Datacubed team has decades of experience in the biomedical sciences, behavioral economics, information technology, and video game engineering.
Chief Executive Officer
Brett has spent the past two decades as a life sciences industry executive, taking several companies from infancy to market leader. In recognition of his career achievements in ‘Tackling the Impediments to Clinical Trials’, Kleger was named to the PharmaVoice 100 in 2018.
Prior to joining Datacubed Health, Brett served as the Chief Commercial Officer for DrugDev, where he led exponential growth of their site facing technologies to support clinical operations. Following an acquisition by IQVIA, he spearheaded clinical technology growth across IQVIA Technologies. Previously, he was the founder of IMS Health’s first clinical trial division, lead the product and services division for Acurian, and practiced as a health care attorney. Brett holds a Bachelor’s in Management Statistics from the University of Maryland – College Park, and a Juris Doctorate from Villanova University School of Law.
Paul W. Glimcher, Ph.D.
Chairman & Chief Scientific Officer
A neuroscientist, psychologist, economist and entrepreneur who holds the Julius Silver, Rosyln S. Silver and Enid Silver Winslow Professorship at New York University (NYU)
He is also a professor in the Department of Neuroscience and Physiology of Neuroscience Institute at NYU Langone School of Medicine. Professor Glimcher is the founder and Director of NYU’s Institute for the Study of Decision Making, and the Principal Investigator of Glimcher Lab in NYU Langone Health. Professor Glimcher is one of the foremost researchers focused on the study of human behavior and decision-making and is known for his central role in founding and developing the field of neuroeconomics which takes an interdisciplinary approach to understand how humans make decisions. Professor Glimcher’s research aims to describe the neural events that underlie behavioral decision-making using tools from economics, psychology, and neuroscience. His research has made contributions to understanding how value is encoded in the brain and how the brain uses those neural representations of value to guide decision-making.
A graduate of Princeton University and The University of Pennsylvania, Professor Glimcher is a fellow of the American Association for the Advancement of Science and the McKnight, Whitehall, Klingenstein, and McDonnell Foundations, as well as a member of the Dana Alliance for Brain Initiatives. He also plays a prominent role with the U.S. National Academies of Science, Engineering, and Medicine, where he has served on numerous advisory boards and research study committees. In addition to the many books and scholarly papers he has written in the field of neuroeconomics, he is the lead editor of the textbook, Neuroeconomics: Decision-Making and the Brain, now in its second edition. His textbook received the American Association of Publishers PROSE Award for Excellence in the Social Sciences.
Chief Commercial Officer
Scott has a strong track record of more than 25 years building and leading teams that create value in life sciences. A proven innovator, Scott has driven monetization of novel solutions in drug development spanning start-ups to industry leaders.
Most recently, Scott led a global business development team consolidating multiple acquisitions of specialized clinical investigator networks. Scott was a Hollingsworth Scholar at the Eshelman School of Pharmacy, University of North Carolina, Chapel Hill where he graduated with highest honors and distinction.
Chief Operating Officer
Brent has spent the past two decades as a strategy and project executive in the public and private sectors, specializing in technology and risk management industries in The United States and abroad.
Prior to joining Datacubed Health, Mr. Schimke worked for 11 years for The City of New York and its public safety agencies overseeing, directing and organizing business activities and processes. Mr. Schimke served in The Department of Information Technology and Telecommunications where he helped oversee the city’s emerging use of management information systems, including a $2 billion mayoral initiative to transform how the police, fire and emergency medical forces communicate. Mr. Schimke played a leading role in transforming how 911 call centers communicate and operate. Mr. Schimke has also worked at start-ups and young, emerging companies as well as at AT&T, MicroAge and Boeing. Mr. Schimke earned his M.S. in Industrial Administration at Carnegie Mellon University and his B.A at Whitman College.
Chief Financial Officer
Alexander Bakal has spent his career of more than a quarter century as a financial executive, with experience in venture capital, mergers and acquisitions, private equity and corporate finance.
Alexander Bakal has a thirty-year career as a financial executive in mergers and acquisitions, private equity, corporate finance, and investing in alternative assets and venture capital. In 1999, he co-founded (and currently still manages) Orion Partners LLC, a tax structuring and investment firm based in New York City. Prior to that he worked as a managing director at CIBC World Markets, where he marketed structured products to US multinational corporations, and before that he worked at Goldman Sachs in Mergers and Acquisitions in New York and London. Mr. Bakal received his MBA from the Stanford University Graduate School of Business and his A.B., summa cum laude in Chemistry from Harvard University.
Chief Compliance and Administrative Officer
Samanta Shaw has spent more than a decade in management and operations in the nonprofit sector.
Ms. Shaw is a co-founder, and the Chief Compliance and Administrative Officer for Datacubed Health. Prior to that, she was the Chief Operating Officer of The Human Project, a quest to develop the world’s most extensive and incisive database of human behavior, environmental influences, and genetic expressions through a study of 10,000 individuals over 20 years. Ms. Shaw was also a founding Associate Director for the Institute for the Study of Decision Making at New York University and the Business Manager for the International Society for Neuroeconomics. She received her B.A. in Psychology, Education and Chemistry at the NYU College of Arts and Sciences.